Unichem receives ANDA approval for hypertension drug
Drug Approval

Unichem receives ANDA approval for hypertension drug

Nebivolol is used alone or together with other medicines to treat high blood pressure

  • By IPP Bureau | March 16, 2022

Unichem Laboratories has received ANDA approval for its Nebivolol tablets 2.5 mg, 5 mg, 10 mg, and 20 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Bystolic (nebivolol) tablets 2.5 mg, 5 mg, 10 mg, and 20 mg, of Allergan Sales, LLC.

Nebivolol is used alone or together with other medicines to treat high blood pressure (hypertension).

The product will be commercialized from Unichem's Ghaziabad Plant.

Upcoming E-conference

Other Related stories

Startup

Digitization